Quentin Rodney Regestein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hot Flashes | 5 | 2017 | 317 | 1.800 |
Why?
|
| Postmenopause | 7 | 2018 | 2461 | 1.670 |
Why?
|
| Menopause | 11 | 2017 | 1626 | 1.140 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 16 | 2014 | 1004 | 1.020 |
Why?
|
| Sleep | 12 | 2016 | 4623 | 0.480 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2014 | 944 | 0.480 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2014 | 162 | 0.450 |
Why?
|
| Problem Solving | 1 | 2016 | 440 | 0.450 |
Why?
|
| Perimenopause | 1 | 2014 | 139 | 0.440 |
Why?
|
| Affect | 3 | 2015 | 1476 | 0.430 |
Why?
|
| Valerian | 1 | 2011 | 3 | 0.410 |
Why?
|
| Methyltestosterone | 2 | 2001 | 19 | 0.410 |
Why?
|
| Vasomotor System | 1 | 2012 | 209 | 0.400 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2010 | 37 | 0.380 |
Why?
|
| Hormone Replacement Therapy | 3 | 2001 | 745 | 0.370 |
Why?
|
| Personality | 1 | 2014 | 552 | 0.370 |
Why?
|
| Attention | 3 | 2017 | 2400 | 0.370 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2010 | 15 | 0.360 |
Why?
|
| Arousal | 7 | 2006 | 1165 | 0.360 |
Why?
|
| Cyclohexanols | 1 | 2010 | 127 | 0.360 |
Why?
|
| Sleep Deprivation | 3 | 2006 | 832 | 0.350 |
Why?
|
| Cognition | 4 | 2017 | 6770 | 0.320 |
Why?
|
| Plant Extracts | 1 | 2011 | 471 | 0.310 |
Why?
|
| Citalopram | 1 | 2010 | 403 | 0.300 |
Why?
|
| Women's Health | 2 | 2015 | 2034 | 0.290 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2005 | 1203 | 0.280 |
Why?
|
| Depression | 10 | 2018 | 7766 | 0.280 |
Why?
|
| Health Status | 3 | 2016 | 4034 | 0.240 |
Why?
|
| Self Report | 1 | 2015 | 3558 | 0.240 |
Why?
|
| Estrogens, Conjugated (USP) | 3 | 2001 | 275 | 0.230 |
Why?
|
| Mood Disorders | 1 | 2010 | 1106 | 0.220 |
Why?
|
| Self-Assessment | 2 | 2004 | 390 | 0.220 |
Why?
|
| Circadian Rhythm | 12 | 2010 | 2624 | 0.210 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2010 | 6038 | 0.210 |
Why?
|
| Sleep Stages | 7 | 1995 | 686 | 0.190 |
Why?
|
| Testosterone Congeners | 1 | 2001 | 62 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2016 | 8554 | 0.180 |
Why?
|
| Neuropsychological Tests | 5 | 2021 | 6993 | 0.180 |
Why?
|
| Progesterone | 2 | 2001 | 776 | 0.160 |
Why?
|
| Cognition Disorders | 3 | 2017 | 4043 | 0.160 |
Why?
|
| Female | 54 | 2018 | 380194 | 0.150 |
Why?
|
| Estrogens | 3 | 2001 | 1566 | 0.150 |
Why?
|
| Somatoform Disorders | 1 | 2001 | 423 | 0.150 |
Why?
|
| Pandemics | 1 | 2018 | 8388 | 0.150 |
Why?
|
| Ethics, Medical | 2 | 2000 | 792 | 0.140 |
Why?
|
| Caffeine | 3 | 2010 | 699 | 0.140 |
Why?
|
| Humans | 75 | 2019 | 744343 | 0.140 |
Why?
|
| Psychiatry | 3 | 2000 | 1695 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2000 | 950 | 0.120 |
Why?
|
| Philosophy | 1 | 1993 | 66 | 0.110 |
Why?
|
| Consciousness Disorders | 1 | 1997 | 418 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 4644 | 0.110 |
Why?
|
| Behavioral Research | 1 | 1992 | 54 | 0.110 |
Why?
|
| Polysomnography | 2 | 1997 | 1776 | 0.100 |
Why?
|
| Narcolepsy | 2 | 1986 | 195 | 0.100 |
Why?
|
| Dementia | 3 | 2019 | 2518 | 0.100 |
Why?
|
| Avoidance Learning | 2 | 1986 | 233 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2010 | 1030 | 0.100 |
Why?
|
| Research Subjects | 1 | 1992 | 239 | 0.090 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2010 | 129 | 0.090 |
Why?
|
| Middle Aged | 28 | 2016 | 213383 | 0.080 |
Why?
|
| Fibromyalgia | 1 | 1993 | 388 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2000 | 1643 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 5 | 1995 | 1162 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 1345 | 0.080 |
Why?
|
| Electroencephalography | 7 | 2001 | 6150 | 0.080 |
Why?
|
| Aged | 19 | 2019 | 163280 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 1991 | 565 | 0.070 |
Why?
|
| Hydromorphone | 2 | 1987 | 65 | 0.070 |
Why?
|
| Institutionalization | 1 | 1987 | 104 | 0.070 |
Why?
|
| Anxiety | 2 | 2001 | 4297 | 0.070 |
Why?
|
| Antidepressive Agents | 6 | 2010 | 2838 | 0.070 |
Why?
|
| Adenoma | 2 | 2017 | 2174 | 0.070 |
Why?
|
| Electroconvulsive Therapy | 4 | 1980 | 477 | 0.070 |
Why?
|
| Sleep Arousal Disorders | 1 | 2006 | 11 | 0.070 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 1989 | 271 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 1993 | 1547 | 0.070 |
Why?
|
| Temazepam | 1 | 1985 | 6 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.070 |
Why?
|
| Triazolam | 1 | 1985 | 16 | 0.070 |
Why?
|
| Informed Consent | 1 | 1992 | 995 | 0.070 |
Why?
|
| Cross-Over Studies | 2 | 2001 | 2029 | 0.070 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2002 | 0.070 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1985 | 67 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3057 | 0.070 |
Why?
|
| Respiratory System | 1 | 1988 | 557 | 0.060 |
Why?
|
| Memory | 2 | 2017 | 2174 | 0.060 |
Why?
|
| Sleep, REM | 6 | 1981 | 595 | 0.060 |
Why?
|
| Alpha Rhythm | 3 | 1993 | 120 | 0.060 |
Why?
|
| Universities | 1 | 2010 | 956 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1953 | 0.060 |
Why?
|
| Ohio | 1 | 2004 | 337 | 0.060 |
Why?
|
| Trazodone | 1 | 1983 | 66 | 0.060 |
Why?
|
| Glioma | 1 | 2018 | 3401 | 0.060 |
Why?
|
| Health Behavior | 1 | 1994 | 2636 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2006 | 772 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 1985 | 390 | 0.050 |
Why?
|
| Pain | 2 | 1993 | 4986 | 0.050 |
Why?
|
| Research | 2 | 2010 | 1999 | 0.050 |
Why?
|
| Catatonia | 2 | 1977 | 158 | 0.050 |
Why?
|
| Phototherapy | 2 | 1995 | 377 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 1986 | 1826 | 0.050 |
Why?
|
| Adult | 29 | 2006 | 214055 | 0.050 |
Why?
|
| Esterification | 1 | 2001 | 36 | 0.050 |
Why?
|
| Medroxyprogesterone | 1 | 2001 | 37 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2006 | 1354 | 0.050 |
Why?
|
| Hippocampus | 2 | 1986 | 3675 | 0.050 |
Why?
|
| Students | 1 | 2010 | 1654 | 0.040 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1980 | 135 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2015 | 77449 | 0.040 |
Why?
|
| Pedophilia | 1 | 1978 | 8 | 0.040 |
Why?
|
| Depressive Disorder | 3 | 2006 | 3748 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9959 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 1986 | 1403 | 0.040 |
Why?
|
| Relaxation Therapy | 3 | 1995 | 178 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1980 | 2268 | 0.040 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 8863 | 0.040 |
Why?
|
| Hypogonadism | 2 | 1981 | 799 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2001 | 12026 | 0.040 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 1977 | 43 | 0.040 |
Why?
|
| Male | 31 | 2006 | 350118 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 1992 | 4258 | 0.040 |
Why?
|
| Thrombophlebitis | 1 | 1977 | 309 | 0.040 |
Why?
|
| Random Allocation | 1 | 2001 | 2429 | 0.040 |
Why?
|
| Dreams | 1 | 1977 | 147 | 0.030 |
Why?
|
| Public Opinion | 1 | 2000 | 477 | 0.030 |
Why?
|
| Hospitals, General | 1 | 1980 | 749 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15295 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 2017 | 339 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12745 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 1975 | 113 | 0.030 |
Why?
|
| Research Design | 1 | 2010 | 5987 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3508 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 1976 | 313 | 0.030 |
Why?
|
| Adolescent | 7 | 2010 | 85781 | 0.030 |
Why?
|
| Wakefulness | 2 | 1993 | 1245 | 0.030 |
Why?
|
| Time Factors | 6 | 2001 | 40075 | 0.030 |
Why?
|
| Biological Psychiatry | 1 | 1993 | 25 | 0.030 |
Why?
|
| Movement Disorders | 1 | 1977 | 445 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.030 |
Why?
|
| Massachusetts | 2 | 2004 | 8663 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4933 | 0.030 |
Why?
|
| Feedback | 2 | 1973 | 795 | 0.030 |
Why?
|
| Piperazines | 1 | 1983 | 2488 | 0.030 |
Why?
|
| Electroshock | 2 | 1986 | 122 | 0.030 |
Why?
|
| Head | 1 | 1977 | 880 | 0.020 |
Why?
|
| Motor Activity | 1 | 2001 | 2714 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2001 | 6459 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1972 | 249 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 1971 | 166 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1972 | 370 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 525 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.020 |
Why?
|
| Tryptophan | 1 | 1972 | 478 | 0.020 |
Why?
|
| Urination Disorders | 1 | 1971 | 241 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1975 | 2726 | 0.020 |
Why?
|
| Music | 1 | 1993 | 263 | 0.020 |
Why?
|
| Periodicity | 1 | 1971 | 363 | 0.020 |
Why?
|
| Melatonin | 1 | 1995 | 721 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1975 | 1047 | 0.020 |
Why?
|
| Fetus | 2 | 1975 | 1880 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1981 | 744 | 0.020 |
Why?
|
| Methaqualone | 1 | 1987 | 4 | 0.020 |
Why?
|
| Luteinizing Hormone | 2 | 1981 | 869 | 0.020 |
Why?
|
| Trust | 1 | 1992 | 505 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 15540 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2001 | 63114 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 2 | 1986 | 1148 | 0.020 |
Why?
|
| Convulsive Therapy | 1 | 1966 | 3 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1987 | 193 | 0.020 |
Why?
|
| Diazepam | 1 | 1987 | 205 | 0.020 |
Why?
|
| Mental Disorders | 4 | 1980 | 6600 | 0.020 |
Why?
|
| Hostility | 2 | 1985 | 189 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4215 | 0.020 |
Why?
|
| Stress, Psychological | 3 | 1976 | 4245 | 0.020 |
Why?
|
| Somnambulism | 1 | 1985 | 13 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 235 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1999 | 8324 | 0.020 |
Why?
|
| Panic | 1 | 1985 | 106 | 0.020 |
Why?
|
| Occupational Health | 1 | 1991 | 809 | 0.020 |
Why?
|
| Translating | 1 | 2006 | 144 | 0.020 |
Why?
|
| Family | 2 | 1991 | 3147 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 1986 | 193 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 1977 | 2376 | 0.020 |
Why?
|
| Quality of Life | 1 | 2006 | 12804 | 0.020 |
Why?
|
| Heart Rate | 1 | 1976 | 4091 | 0.020 |
Why?
|
| Half-Life | 1 | 1985 | 661 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 56430 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1995 | 2531 | 0.010 |
Why?
|
| Chronic Disease | 3 | 1988 | 9146 | 0.010 |
Why?
|
| Psychomotor Agitation | 1 | 1985 | 293 | 0.010 |
Why?
|
| Oxygen | 1 | 1995 | 4189 | 0.010 |
Why?
|
| Sweden | 1 | 2006 | 1345 | 0.010 |
Why?
|
| Anger | 1 | 1985 | 402 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1983 | 129 | 0.010 |
Why?
|
| Physical Exertion | 2 | 1976 | 695 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 57776 | 0.010 |
Why?
|
| Psychotherapy | 2 | 1983 | 1643 | 0.010 |
Why?
|
| Climacteric | 1 | 1981 | 57 | 0.010 |
Why?
|
| MMPI | 1 | 1981 | 86 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1994 | 3209 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1738 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 10388 | 0.010 |
Why?
|
| Electromyography | 2 | 1977 | 1379 | 0.010 |
Why?
|
| Wechsler Scales | 2 | 1983 | 260 | 0.010 |
Why?
|
| Hypertension | 1 | 1980 | 8480 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1986 | 2375 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 1129 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1983 | 783 | 0.010 |
Why?
|
| Health Policy | 1 | 1991 | 2661 | 0.010 |
Why?
|
| Methylphenidate | 1 | 1983 | 473 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 1017 | 0.010 |
Why?
|
| Prolactin | 1 | 1980 | 669 | 0.010 |
Why?
|
| United States | 2 | 2000 | 69872 | 0.010 |
Why?
|
| Child | 2 | 1997 | 77709 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 552 | 0.010 |
Why?
|
| Macaca | 1 | 1979 | 440 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6365 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
| Behavior | 1 | 1979 | 561 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 191 | 0.010 |
Why?
|
| Brain | 2 | 1973 | 26385 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 1975 | 84 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1976 | 265 | 0.010 |
Why?
|
| Age Factors | 4 | 1980 | 18370 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1980 | 748 | 0.010 |
Why?
|
| Relaxation | 1 | 1975 | 50 | 0.010 |
Why?
|
| Homosexuality | 1 | 1975 | 262 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1983 | 1901 | 0.010 |
Why?
|
| Psychophysiologic Disorders | 1 | 1976 | 228 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1975 | 1386 | 0.010 |
Why?
|
| Electrooculography | 1 | 1973 | 118 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1983 | 1470 | 0.010 |
Why?
|
| Heart Block | 1 | 1975 | 410 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1976 | 538 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1972 | 39 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1972 | 40 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1988 | 39050 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1975 | 317 | 0.010 |
Why?
|
| Psychopathology | 1 | 1975 | 409 | 0.010 |
Why?
|
| Spironolactone | 1 | 1975 | 382 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
| Personality Disorders | 1 | 1976 | 713 | 0.010 |
Why?
|
| Mental Health | 1 | 2006 | 3019 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1976 | 789 | 0.010 |
Why?
|
| Diuresis | 1 | 1971 | 116 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1971 | 191 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 72290 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1992 | 23338 | 0.010 |
Why?
|
| Dogs | 1 | 1976 | 3912 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6669 | 0.010 |
Why?
|
| Appetite | 1 | 1972 | 243 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 1971 | 202 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1972 | 341 | 0.010 |
Why?
|
| Environment | 1 | 1976 | 1124 | 0.010 |
Why?
|
| Meningioma | 1 | 1978 | 1209 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1980 | 2684 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1972 | 407 | 0.010 |
Why?
|
| Psychological Tests | 2 | 1983 | 651 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1978 | 1241 | 0.010 |
Why?
|
| Animals | 6 | 1986 | 168757 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 21746 | 0.000 |
Why?
|
| Potassium | 1 | 1972 | 1336 | 0.000 |
Why?
|
| Schizophrenia | 1 | 1966 | 6882 | 0.000 |
Why?
|
| Fatigue | 1 | 1975 | 1531 | 0.000 |
Why?
|
| Gestational Age | 1 | 1975 | 3493 | 0.000 |
Why?
|
| Acute Disease | 1 | 1977 | 7149 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1972 | 740 | 0.000 |
Why?
|
| Alcoholism | 1 | 1976 | 1906 | 0.000 |
Why?
|
| Eating | 1 | 1972 | 1536 | 0.000 |
Why?
|
| Primary Health Care | 1 | 1979 | 4558 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1976 | 3046 | 0.000 |
Why?
|
| Emotions | 1 | 1971 | 2661 | 0.000 |
Why?
|
| Smoking | 1 | 1976 | 8987 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1978 | 11727 | 0.000 |
Why?
|
| Pregnancy | 2 | 1975 | 29144 | 0.000 |
Why?
|
| Higher Nervous Activity | 1 | 1976 | 4 | 0.000 |
Why?
|
| Digitalis Glycosides | 1 | 1976 | 47 | 0.000 |
Why?
|
| Placebos | 1 | 1980 | 1676 | 0.000 |
Why?
|
| Phenytoin | 1 | 1976 | 197 | 0.000 |
Why?
|
| Hypospadias | 1 | 1975 | 92 | 0.000 |
Why?
|
| Aggression | 1 | 1979 | 753 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1972 | 6364 | 0.000 |
Why?
|
| Propranolol | 1 | 1976 | 502 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1980 | 2373 | 0.000 |
Why?
|
| Thinking | 1 | 1976 | 319 | 0.000 |
Why?
|
| Interview, Psychological | 1 | 1976 | 812 | 0.000 |
Why?
|
| Rats | 2 | 1980 | 24260 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 12959 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1976 | 2250 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1976 | 6489 | 0.000 |
Why?
|
| Recurrence | 1 | 1976 | 8340 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1976 | 6442 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1976 | 6077 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1976 | 3537 | 0.000 |
Why?
|